James Solomon

Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma

Aleksandar Sekulić, Michael R. Migden, Anthony E. Oro et al. · New England Journal of Medicine · 2012 · 1.4K citations · Full text

Medicine, Oncology, Pharmacology +17

Pivotal ERIVANCE basal cell carcinoma (BCC) study: 12-month update of efficacy and safety of vismodegib in advanced BCC

Aleksandar Sekulić, Michael R. Migden, Karl D. Lewis et al. · Journal of the American Academy of Dermatology · 2015 · 209 citations · Full text

Medicine, Dermatology, Oncology +8

Expanded access study of patients with advanced basal cell carcinoma treated with the Hedgehog pathway inhibitor, vismodegib

Anne Lynn S. Chang, James Solomon, John D. Hainsworth et al. · Journal of the American Academy of Dermatology · 2013 · 188 citations · Full text

Medicine, Oncology, Pharmacology +8

Ixekizumab treatment shows a neutral impact on cardiovascular parameters in patients with moderate-to-severe plaque psoriasis: Results from UNCOVER-1, UNCOVER-2, and UNCOVER-3

Alexander Egeberg, Jashin J. Wu, Neil J. Korman et al. · Journal of the American Academy of Dermatology · 2018 · 63 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +11

The magnitude of COVID-19's effect on the timely management of melanoma and nonmelanoma skin cancers

Justin W. Marson, Brittany Maner, Tanner Harding et al. · Journal of the American Academy of Dermatology · 2021 · 59 citations · Full text

Medicine, Dermatology, Oncology +14